Biomarkers of chronic uveitis in juvenile idiopathic arthritis: Predictive value of antihistone antibodies and antinuclear antibodies

Journal of Rheumatology

Volumn 36, Issue 8, 2009, Pages 1737-1743

  Nordal, Ellen B ^a,b   Songstad, Nils T ^b   Berntson, Lillemor ^c   Moen, Torolf ^d   Straume, Bjørn ^b   Rygg, Marite ^d,e  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY CHILDREN S HOSPITAL   (Sweden)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Antinuclear antibodies; Disease biomarker; Elisa; Histones; Juvenile idiopathic arthritis; Uveitis

Indexed keywords

ANTINUCLEAR ANTIBODY; BIOLOGICAL MARKER; HISTONE ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE EXAMINATION; FEMALE; HEP 2 CELL; HUMAN; IMMUNOFLUORESCENCE; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; UVEITIS;

ANTIBODIES, ANTINUCLEAR; ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; CHILD; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HISTONES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LONGITUDINAL STUDIES; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; UVEITIS;

EID: 68849107318     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.081318     Document Type: Article

References (36)

1. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
2. Ravelli A, Felici E, Magni-Manzoni S, et al. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheum 2005;52:826-32.
3. Cassidy J, Kivlin J, Lindsley C, Nocton J. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 2006;117:1843-5.
4. Kotaniemi K, Kautiainen H, Karma A, Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology 2001;108:2071-5.
5. Chalom EC, Goldsmith DP, Koehler MA, et al. Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol 1997;24:2031-4.
6. Foster H, Ramanan A. 'The eyes have it!' The need to improve awareness and access to early ophthalmological screening for juvenile idiopathic arthritis associated uveitis. Rheumatology 2009;48:330-1. Epub 2009 Feb 7.
7. Reininga JK, Los LI, Wulffraat NM, Armbrust W. The evaluation of uveitis in juvenile idiopathic arthritis (JIA) patients: are current ophthalmologic screening guidelines adequate? Clin Exp Rheumatol 2008;26:367-72.
8. Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology 2007;46:1015-9.
9. Southwood TR, Ryder CA. Ophthalmological screening in juvenile arthritis: should the frequency of screening be based on the risk of developing chronic iridocyclitis? Br J Rheumatol 1992;31:633-4.
10. Reiff A, Haubruck H, Amos MD. Evaluation of a recombinant antigen enzyme-linked immunosorbent assay (ELISA) in the diagnostics of antinuclear antibodies (ANA) in children with rheumatic disorders. Clin Rheumatol 2002;21:103-7.
11. Osborn TG, Patel NJ, Moore TI, Zuckner J. Use of the HEp-2 cell substrate in the detection of antinuclear antibodies in juvenile rheumatoid arthritis. Arthritis Rheum 1984;27:1286-9.
12. Arguedas O, Fasth A, Andersson-Gare B, Porras O. Juvenile chronic arthritis in urban San Jose, Costa Rica: a 2 year prospective study. J Rheumatol 1998;25:1844-50.
13. Nossent H, Rekvig OP. Antinuclear antibody screening in this new millennium: farewell to the microscope? Scand J Rheumatol 2001;30:123-6.
14. Fawcett PT, Rose CD, Gibney KM, Emerich MJ, Athreya BH, Doughty RA. Use of ELISA to measure antinuclear antibodies in children with juvenile rheumatoid arthritis. J Rheumatol 1999;26:1822-6.
15. Leak AM, Woo P. Juvenile chronic arthritis, chronic iridocyclitis, and reactivity to histones. Ann Rheum Dis 1991;50:653-7.
16. Ingegnoli F, Del Papa N, Comina DP, et al. Autoantibodies to chromatin: prevalence and clinical significance in juvenile rheumatoid arthritis. Clin Exp Rheumatol 2004;22:499-501.
17. Szer IS, Sierakowska H, Szer W. A novel autoantibody to the putative oncoprotein DEK in pauciarticular onset juvenile rheumatoid arthritis. J Rheumatol 1994;21:2136-42.
18. Malleson PN, Sailer M, Mackinnon MJ. Usefulness of antinuclear antibody testing to screen for rheumatic diseases. Arch Dis Child 1997;77:299-304.
19. Monestier M, Losman JA, Fasy TM, et al. Antihistone antibodies in antinuclear antibody-positive juvenile arthritis. Arthritis Rheum 1990;33:1836-41.
20. Ostensen M, Fredriksen K, Kass E, Rekvig OP. Identification of antihistone antibodies in subsets of juvenile chronic arthritis. Ann Rheum Dis 1989;48:114-7.
21. Leak AM, Tuaillon N, Muller S, Woo P. Study of antibodies to histones and histone synthetic peptides in pauciarticular juvenile chronic arthritis. Br J Rheumatol 1993;32:426-31.
22. Stemmer C, Tuaillon N, Prieur AM, Muller S. Mapping of B-cell epitopes recognized by antibodies to histones in subsets of juvenile chronic arthritis. Clin Immunol Immunopathol 1995;76:82-9.
23. Malleson P, Petty RE, Fung M, Candido EP. Reactivity of antinuclear antibodies with histones and other antigens in juvenile rheumatoid arthritis. Arthritis Rheum 1989;32:919-23.
24. Massa M, De Benedetti F, Pignatti P, Albani S, Monestier M, Martini A. Lack of temporal association of iridocyclitis with IgG reactivities to core histones and nucleosome subparticles in pauciarticular juvenile chronic arthritis. Br J Rheumatol 1995;34:507-11.
25. Pauls JD, Silverman E, Laxer RM, Fritzler MJ. Antibodies to histones H1 and H5 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheum 1989;32:877-83.
26. Gonzalez C, Garcia-Berrocal B, Perez M, Navajo JA, Herraez O, Gonzalez-Buitrago JM. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients. Clin Chim Acta 2005;359:109-14.
27. United Kingdom National External Quality Assessment Service. Immqas.org.uk. Sheffield: Immunology Quality Services. Annual report 2007. [Internet. Accessed May 15, 2009.] Available from: http://www.immqas.org.uk/ immqas%20annual%20report%202007/UK%20NEQAS%20Annual%20Report%202007%20V8.pdf
28. Berntson L, Andersson GB, Fasth A, et al. Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol 2003;30:2275-82.
29. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005;140:509-16.
30. Saurenmann RK, Levin AV, Feldman BM, et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: A long-term follow-up study. Arthritis Rheum 2007;56:647-57.
31. Fritzler MJ, Wiik A, Tan EM, et al. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories. J Rheumatol 2003;30:2374-81.
32. Pharmacia Deutschland GmbH Diagnostics Division. Varelisa Histone Antibodies, Directions for Use 164-01/01. Oct 2003;7.
33. Kump LI, Castaneda RA, Androudi SN, Reed GF, Foster CS. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology 2006;113:1874-7.
34. Rosenberg AM, Hauta SA, Prokopchuk PA, Romanchuk KG. Studies on associations of antinuclear antibodies with antibodies to an uveitogenic peptide of retinal S antigen in children with uveitis. J Rheumatol 1996;23:370-3.
35. Zak M, Fledelius H, Pedersen FK. Ocular complications and visual outcome in juvenile chronic arthritis: a 25-year follow-up study. Acta Ophthalmol Scand 2003;81:211-5.
36. Kotaniemi K, Arkela-Kautiainen M, Haapasaari J, Leirisalo-Repo M. Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis 2005;64:871-4.